December 28, 2014 3:12 AM ET

Biotechnology

Company Overview of Medicago Inc.

Company Overview

Medicago Inc., a clinical-stage biotechnology company, develops novel vaccines and therapeutic proteins to treat various infectious diseases worldwide. The company develops its vaccines based on its proprietary technologies comprising the plant-based Proficia technology and Virus-Like Particles (VLP) technology. Its product candidates include H5N1 pandemic influenza VLP vaccine, which has completed a Phase II human clinical trial; and seasonal influenza and H1N1 vaccines. The company’s products under development also comprise non-influenza VLP and rabies vaccine candidates. It has a strategic alliance with Mitsubishi Tanabe Pharma Corporation to develop a Rotavirus vaccine candidate; and res...

1020 Route de l'Église

Suite 600

Quebec, QC G1V 3V9

Canada

Founded in 1997

Phone:

418-658-9393

Fax:

418-658-6699

Key Executives for Medicago Inc.

Chief Executive Officer
Executive Vice President of Operations
Director of Investor Relations & Communications
Vice President of Business Development
Vice-President of Quality Assurance and Quality Control
Compensation as of Fiscal Year 2014.

Medicago Inc. Key Developments

Medicago Inc. Announces Financial Results for the Second Quarter and Six Months Ended June 30, 2013

Medicago Inc. announced financial results for the second quarter and six months ended June 30, 2013. For the quarter, the company reported revenues of $918,000. Net loss was $9,073,000 or $0.04 per basic and diluted share compared to a net loss of $8,099,000 or $0.04 per basic and diluted share for the same period a year ago. For the six-months, the company reported revenues of $1,337,000. Net loss was $17,789,000 or $0.07 per basic and diluted share compared to $17,087,000 or $0.07 per basic and diluted share for the same period a year ago.

Medicago Inc. to Report Q2, 2013 Results on Aug 09, 2013

Medicago Inc. announced that they will report Q2, 2013 results After-Market on Aug 09, 2013

Medicago Inc., Special/Extraordinary Shareholders Meeting, Aug 29, 2013

Medicago Inc., Special/Extraordinary Shareholders Meeting, Aug 29, 2013., at 11:00 Eastern Daylight. Location: McCarthy Tétrault LLP's office located at 1000. Agenda: To discuss plan of arrangement involving Mitsubishi Tanabe Pharma Corporation.

Similar Private Companies By Industry

Company Name Region
IntelligentNano Inc. Americas
Valocor Therapeutics, Inc. Americas
IMBiotechnologies Ltd. Americas
Gilead Alberta ULC Americas
Inocucor, Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Medicago Inc., please visit www.medicago.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.